Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04604093 · ClinicalTrials.gov registry record
Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 358
- Enrollment target
NCT04604093 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 358 participants.
The verdict
NCT04604093 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 358 participants
- Enrollment target
Study Summary
A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System to the current standard of care (SMBG, self-monitoring of blood glucose) on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen.
Interventions
- DEVICE SMBG Meter
- DEVICE FreeStyle Libre 2 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2023-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04604093
The ClinicalTrials.gov registry entry for NCT04604093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMBG Meter is the first listed.
NCT04604093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04604093 about?
NCT04604093 is a clinical study titled "Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes". A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System to the current standard of care (SMBG, self-monitoring of blood glucose) on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not ad...
What is the current status of trial NCT04604093?
This trial is currently completed. The enrollment target is 358 participants. The study started on 2020-10-20. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04604093?
The interventions under investigation include: SMBG Meter (DEVICE), FreeStyle Libre 2 System (DEVICE).
Who is sponsoring clinical trial NCT04604093?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.